Gastric Cancer Diagnostic Market Forecast 2026: Market Size, Competitive Landscape And Growth Drivers

Gastric Cancer Diagnostic Market Report

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Gastric Cancer Diagnostic Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?

The gastric cancer diagnostic market has shown significant growth in recent times. It is forecast to increase from $2.78 billion in 2025 to $2.98 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.2%. This historical expansion can be attributed to several factors, including the limited availability of fluorescent probes, a reliance on traditional single-color FISH methods, growing genetic research initiatives, an increase in hospital and laboratory infrastructure, and the adoption of basic cytogenetic diagnostics.

Significant expansion is anticipated for the gastric cancer diagnostic market in the upcoming years. Projections indicate its value will reach $3.87 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. This growth during the forecast period is propelled by factors such as the creation of multiplex and high-throughput probes, the increasing need for precision medicine, broader genetic and pharmaceutical research, improvements in imaging and quantification technologies, and stricter regulatory compliance and quality standards. Key trends expected over the forecast period encompass a greater uptake of multiplex and high-throughput FISH probes, an increase in genetic and molecular diagnostic applications, expanded utilization in clinical and pharmaceutical research, the incorporation of advanced imaging and analysis technologies, and a sharpened emphasis on probe accuracy and sensitivity.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=90141428&type=smp&name=Gastric%20Cancer%20Diagnostic%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Gastric Cancer Diagnostic Market Growth Factors Behind Sustained Expansion

The increasing occurrence of gastric cancer is anticipated to drive the expansion of the gastric cancer diagnostic market in the future. Gastric cancer is defined as a malignant tumor located in the stomach lining, characterized by the uncontrolled proliferation of cells, which creates a mass capable of invading adjacent tissues and metastasizing throughout the body. This growing incidence of gastric cancer stems from unhealthy dietary practices, since a significant intake of salted, smoked, and processed foods elevates the risk of stomach lining damage and subsequent cancer development. Gastric cancer diagnostics assist in diagnosing gastric cancer by allowing for the early identification of malignant lesions, which is crucial for prompt treatment and better patient recovery. These diagnostics improve clinical effectiveness through the provision of accurate and quick results, thereby facilitating enhanced disease management. For example, data from May 2024, published by the American Cancer Society, a US-based nonprofit organization, indicated that new stomach cancer cases totaled 26,890 in 2024, marking an increase from 26,500 cases reported in 2023. Consequently, the escalating incidence of gastric cancer is a key factor propelling the growth of the gastric cancer diagnostic market.

Gastric Cancer Diagnostic Market Segment Breakdown: Which Categories Lead On Revenue?

The gastric cancer diagnostic market covered in this report is segmented –

1) By Diagnostic Type: Endoscopy, Imaging, Biopsy, Laboratory Tests, Biomarker-Based Testing

2) By Product: Reagents And Consumables, Instruments

3) By Technology: Molecular Diagnostics, Immunoassays, Next-Generation Sequencing, Other Technologies

4) By Application: Early Diagnosis, Screening, Monitoring

5) By End User: Hospitals, Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Endoscopy: Conventional Endoscopy, Chromoendoscopy, Narrow Band Imaging, Confocal Laser Endomicroscopy, Capsule Endoscopy

2) By Imaging: Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound

3) By Biopsy: Forceps Biopsy, Needle Biopsy, Endoscopic Ultrasound-Guided Biopsy, Laparoscopic Biopsy

4) By Laboratory Tests: Blood Tests, Stool Tests, Urea Breath Test, Serology

5) By Biomarker-Based Testing: Genetic Testing, Protein Biomarker Testing, Circulating Tumor DNA Testing, Microribonucleic Acid Testing

Gastric Cancer Diagnostic Market Industry Trends Fueling Future Revenue Growth

Companies operating within the gastric cancer diagnostic market are concentrating on the creation of cutting-edge diagnostic instruments, such as artificial intelligence-based endoscopic diagnostic support devices, to enhance both early detection capabilities and diagnostic accuracy. Artificial intelligence-based endoscopic diagnostic support devices are AI-driven tools that assist in identifying and evaluating gastrointestinal abnormalities during an endoscopy. As an example, in March 2024, AI Medical Service Inc., a Japanese medical technology firm, launched GastroAI-model G, an AI-powered system designed to support endoscopic diagnosis. This system helps gastroenterologists during endoscopic procedures by analyzing video images in real time to locate potential cancerous lesions. It leverages deep learning to detect suspicious areas indicative of early gastric cancer, which may require a biopsy or further examination. When these lesions are identified, the system instantly alerts the physician by highlighting the area with a rectangle on the endoscopic screen, thereby improving diagnostic accuracy and enabling earlier cancer detection.

Gastric Cancer Diagnostic Market Competitive Overview And Top Companies

Major companies operating in the gastric cancer diagnostic market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux SA, Qiagen N.V., DiaSorin S.p.A, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc.

View The Full Gastric Cancer Diagnostic Market Report:

https://thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Gastric Cancer Diagnostic Market Top Region: Where Does Most Revenue Come From?

North America was the largest region in the gastric cancer diagnostic market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model